Rafael J Yanez-Munoz
Overview
Explore the profile of Rafael J Yanez-Munoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown S, Yanez-Munoz R, Fuller H
Neural Regen Res
. 2024 Sep;
20(7):2011-2012.
PMID: 39254562
No abstract available.
2.
3.
Yanez-Munoz R, Itzhaki J
Gene Ther
. 2024 Jul;
31(9-10):437-438.
PMID: 39075187
No abstract available.
4.
Seymour L, Thrasher A, Baker A, Griesenbach U, Yanez-Munoz R
Hum Gene Ther
. 2023 Dec;
35(1-2):5-8.
PMID: 38062731
The year 2023 marks the 20th anniversary of the British Society for Gene and Cell Therapy (BSGCT). In these 20 years, the field of gene and cell therapy has gone...
5.
Selvakumaran J, Ursu S, Bowerman M, Lu-Nguyen N, Wood M, Malerba A, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893074
The blood-brain barrier (BBB) is the specialised microvasculature system that shields the central nervous system (CNS) from potentially toxic agents. Attempts to develop therapeutic agents targeting the CNS have been...
6.
Brown S, Soltic D, Synowsky S, Shirran S, Chilcott E, Shorrock H, et al.
Hum Mol Genet
. 2023 Jul;
32(20):2950-2965.
PMID: 37498175
Structural, functional and molecular cardiac defects have been reported in spinal muscular atrophy (SMA) patients and mouse models. Previous quantitative proteomics analyses demonstrated widespread molecular defects in the severe Taiwanese...
7.
Nafchi N, Chilcott E, Brown S, Fuller H, Bowerman M, Yanez-Munoz R
Gene Ther
. 2023 Jun;
30(12):812-825.
PMID: 37322133
Spinal muscular atrophy (SMA) is a neuromuscular disease particularly characterised by degeneration of ventral motor neurons. Survival motor neuron (SMN) 1 gene mutations cause SMA, and gene addition strategies to...
8.
Papaioannou I, Owen J, Yanez-Munoz R
Int J Exp Pathol
. 2023 May;
104(4):154-176.
PMID: 37177842
Rare diseases collectively exact a high toll on society due to their sheer number and overall prevalence. Their heterogeneity, diversity, and nature pose daunting clinical challenges for both management and...
9.
Chilcott E, Muiruri E, Hirst T, Yanez-Munoz R
Gene Ther
. 2022 Nov;
30(1-2):188.
PMID: 36437357
No abstract available.
10.
Chilcott E, Muiruri E, Hirst T, Yanez-Munoz R
Gene Ther
. 2021 Oct;
29(9):498-512.
PMID: 34611322
Spinal muscular atrophy (SMA) is a severe childhood neuromuscular disease for which two genetic therapies, Nusinersen (Spinraza, an antisense oligonucleotide), and AVXS-101 (Zolgensma, an adeno-associated viral vector of serotype 9...